Skip to main content
. 2024 Jul 23;15(8):1351–1357. doi: 10.1021/acsmedchemlett.4c00238

Figure 1.

Figure 1

Structure of the first reported PLPro inhibitor GRL-061721 and its analogues developed by Rutgers University221, Pfizer242, and Oak Ridge National Laboratory253 with their inhibitory and cellular activity reported.